Careers  |  Sign In  |  Register  |   Twitter

Latest in Cardiology

Reuters Health • The Doctor's Channel Daily Newscast

Ranolazine may have a role in elective PCI, pilot study hints

NEW YORK (Reuters Health) – Treatment with the antianginal drug ranolazine before elective percutaneous coronary intervention (PCI) significantly reduced procedure-related myocardial injury in a small pilot study from Italy. “Ranolazine has very few side effects and contraindications, so it would be an...

Reuters Health • The Doctor's Channel Daily Newscast

Major bleeding in transfemoral PCI lower with bivalirudin than heparin

NEW YORK (Reuters Health) – Compared with unfractionated heparin (UFH) monotherapy, bivalirudin use in patients undergoing percutaneous coronary intervention via the femoral artery is associated with significantly decreased risk of bleeding while rates major adverse cardiovascular events (MACEs) are...

Reuters Health • The Doctor's Channel Daily Newscast

No increased risk of intracerebral hemorrhage with statin use

NEW YORK (Reuters Health) – Contrary to some study findings, statin therapy does not increase the risk of intracerebral hemorrhage (ICH) significantly, according to the results of a new meta-analysis reported in the August issue of Stroke online May 15. “The significant reduction in total stroke and...